News | November 13, 2023
Vaishali Pharma posts Q2 FY24 PAT at Rs. 1.70 Cr
he company posted total income during Q2 FY24 at Rs. 12.86 crore
he company posted total income during Q2 FY24 at Rs. 12.86 crore
Lack of technology transfer stands out as a formidable barrier
The newly developed adhesive is available in two different grades. Loctite WT 3001 and Loctite WT 3003 h
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
With the establishment of five different precious metals alloy powder production methods
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
The new gummy capabilities include a dedicated R&D lab, an automated production line, and bottle packaging solutions
Increased capability to produce medicines for challenging diseases including cancer
Subscribe To Our Newsletter & Stay Updated
